Filing Flows › Xenon Pharmaceuticals (XENE) › Recalls, complaints & regulation
Xenon Pharmaceuticals (XENE): clinical trials
Xenon Pharmaceuticals (XENE) beyond its filings: 9 active clinical trials.
Xenon Pharmaceuticals' latest quarter
Xenon Pharmaceuticals, Q1 2025: revenue $7.5M, operating margin -969.8%, net loss $65.0M, operating cash flow −$61.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Xenon Pharmaceuticals have?
9 active studies on ClinicalTrials.gov, 8 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.